{"nct_id":"NCT01569295","title":"Study Evaluating the Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) (Tugela )","status":"COMPLETED","status_verified_date":"2020-03","start_date":"2012-06-15","start_date_type":"ACTUAL","primary_completion_date":"2019-06-10","primary_completion_date_type":"ACTUAL","completion_date":"2019-06-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GILD"]}